Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK

Author： Lafuma Antoine  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.2, 2006-01, pp. : 193-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between Visual Acuity and Medical and Non-Medical Costs in Patients with Wet Age-Related Macular Degeneration in France, Germany and Italy

By Bandello Francesco  

Drugs & Aging, Vol. 25, Iss. 3, 2008-01 ,pp. : 255-268

Adis International

Access to resources Recommend Favorite

The Comparative Medical Costs of Atherothrombotic Disease in European Countries

By Levy E.  

PharmacoEconomics, Vol. 21, Iss. 9, 2003-01 ,pp. : 651-659

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

By Murphy N.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 607-622

Adis International

Access to resources Recommend Favorite

Australian Hospital Pharmacists' Experiences of a UK Non‐Medical Prescribing Course

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 3, 2010-09 ,pp. : 187-193

John Wiley & Sons Inc

Access to resources Recommend Favorite

The obesity drug market will increase more than six-fold over the next 10 years in the USA, France, Germany, Italy, Spain, Japan and the UK

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 639, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite